GL
Genghis Lloyd-Harris
OtherActivePartner at Abingworth
68
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Genghis Lloyd-Harris.
Investment Thesis & Strategy
Abingworth, with partner Genghis Lloyd-Harris, invests in various stages of biotech, diagnostics, health & hospital services, health IT, and medical device companies. They seek to partner with innovative companies that are developing novel solutions in the healthcare space.
Portfolio Companies
Selected investments from their portfolio of 68 companies
L
Labcyte
Other · , 0
P
Pathwork Diagnostics
Other · , 0
S
Senseonics
Other · , 0
C
Chiasma
Biotech · Growth, 0
G
Gynesonics
Healthcare · Series B, 0
R
Reneo Pharmaceuticals
Biotech · Series A, 0
V
Vera Therapeutics
Biotech · Series B, 0
P
Portola Pharmaceuticals
Biotech · Growth, 0
N
Nouscom
Biotech · Series A, 0
V
Vaxcyte
Biotech · Series B, 0
L
Lombard Medical plc
Healthcare · Growth, 0
N
Novexel
Other · , 0
Frequently Asked Questions
Genghis Lloyd-Harris focuses on Series B stage investments.